483
Clive Ballard, M.D.FDA 483 - Clive Ballard, M.D. - May 20, 2022
Record Details
An FDA inspection of Clive Ballard, M.D., a clinical investigator in London, revealed significant issues with the conduct of a clinical study. Observations included the enrollment of ineligible subjects due to failure to follow the investigational plan and a failure to obtain proper informed consent from human subjects prior to study procedures. These findings indicate deficiencies in adherence to study protocols and regulatory requirements for human subject protection.
Open in Dashboard
ID · 19b64d9e-ff02-4f2b-93ad-31278d12dea1